Page 33 - Sciences Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Erythropoietin Drugs Market to Grow US$ 11.9 Billion by 2026 Search jobs Erythropoietin Drugs Market to Grow US$ 11.9 Billion by 2026 Pune, Maharashtra, India, February 8 2021 (Wiredrelease) Allied Analytics –:Allied Market Research published a new report, titled, “Global Erythropoietin Drugs Market is expected to garner $11.9 billion by 2020, registering CAGR of 9.7% during the forecast period 2017 – 2026.  Rising incidences of Cancer, ESRD (End Stage Renal Disease), and HIV have largely contributed to the overwhelming demand for EPO drugs. Approximately 20% o...

BioXcel Therapeutics Inc (NASDAQ: BTAI) plans to finalize study design, dosing, and endpoints for its BXCL501 Phase 3 program in dementia-related agitation. The end of the Phase 2 meeting with the FDA is scheduled in Q2 2021. BXCL501 is an orally dissolving thin film formulation of... Read More...

Dr Reddys Laboratories Ltd has lost 15.47% over last one month compared to 6.47% fall in S&P BSE Healthcare index and 2.8% drop in the SENSEX Dr Reddys Laboratories Ltd fell 3.67% today to trade at Rs 4430. The S&P BSE Healthcare index is down 0.91% to quote at 20440.81. The index is down 6.47 % over last one month. Among the other constituents of the index, Thyrocare Technologies Ltd decreased 3.01% and RPG Life Sciences Ltd lost 2.97% on the day. The S&P BSE Healthcare index went up 48.83 % over last one year compared to the 17.09% surge in benchmark SENSEX. Dr Reddys Laboratories Ltd has l...

Erythropoietin Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027 Published: Dec. 30, 2020 at 8:18 a.m. ET The MarketWatch News Department was not involved in the creation of this content. Dec 30, 2020 (Market Insight Reports) -- The Global Erythropoietin Drugs Market is estimated to value over USD 20 billion by 2027 end at a CAGR of over 11.3% during the forecast period 2020 to 2027. The research report titled Erythropoietin Drugs offers comprehensive information on key driving factors, pricing analysis, market growth trends, b...

Carnival, Alibaba, Myovant Rise; Weibo Falls FOLLOW US ON: Weibo Corp., down $5.98 to $38.33. The China-based social media company reported results that topped Wall Streets forecasts, but also noted some slowing in active users. Ideanomics Inc., up 7 cents to $2.34. The company’s Mobile Energy Global business unit is buying 2,000 units of a ride-hailing vehicle from a Chinese joint venture. Myovant Sciences Ltd., up $4.66 to $27.41. The drugmaker said it’s teaming up with Pfizer to develop hormone blocker relugolix for treatment of cancer and womens health issues. Kinnate Biopharma In...